OneLegacy Partners with XVIVO and Perfusion Solution to Launch the First Ex Vivo Lung Perfusion (EVLP) Center in the Western U.S.
OneLegacy, the nonprofit organ procurement organization serving Southern California, announced the launch of the first in-house Ex Vivo Lung Perfusion (EVLP) program at an organ procurement organization in the Western United States through a new partnership with global medical technology leaders XVIVO and Perfusion Solution. OneLegacy’s Azusa Recovery and Transplant Center offers a specialized donor recovery infrastructure ideal for XVIVO's XPS™ Ex Vivo Lung Perfusion (EVLP) platform and the perfusion specialists, clinical services and equipment provided by Perfusion Solution.
The innovative program allows donated lungs to remain functioning outside the body while specially trained clinical teams evaluate and preserve them for transplantation. By extending the amount of time lungs can be safely assessed, this technology has the potential to make more donor lungs available for transplant, expanding access for transplant centers and ultimately saving more lives.
Together, this partnership gives transplant teams additional time to carefully evaluate donor lungs that might previously have been considered unsuitable for transplantation, increasing opportunities for patients waiting for a lifesaving transplant.
